Circulating Follistatin Predicts Tirzepatide Treatment Outcomes on Type 2 Diabetes

被引：0
|
作者：
Zou, Qi
Engstrom, Gunnar
Pan, Jingxue
Zhang, Jialin
Perisho, Esther J.
Lin, Yanzhu
Wiese, Russell
Wilson, Jonathan M.
Pavo, Imre
Gao, Rui
Duffin, Kevin L.
De Marinis, Yang
机构：
来源：
DIABETES | 2024年 / 73卷
关键词：
D O I：
10.2337/db24-741-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
741-P
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Circulating Progenitor Cell Count Predicts Microvascular Outcomes in Type 2 Diabetic Patients
    Rigato, Mauro
    Bittante, Cristina
    Albiero, Mattia
    Avogaro, Angelo
    Fadini, Gian Paolo
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2015, 100 (07): : 2666 - 2672
  • [42] Obesity treatment and diabetes prevention with tirzepatide
    Schuerfeld, Robin
    DIABETOLOGIE, 2025,
  • [43] Patient-Reported Outcomes in People with Type 2 Diabetes Receiving Tirzepatide in the SURPASS Clinical Trial Programme
    Kristina S. Boye
    Vivian Thuyanh Thieu
    Hélène Sapin
    Clare J. Lee
    Laura Fernández Landó
    Katelyn Brown
    Ross Bray
    Russell J. Wiese
    Hiren Patel
    Ángel Rodríguez
    Maria Yu
    Diabetes Therapy, 2023, 14 : 1833 - 1852
  • [44] Patient-reported outcomes in patients with type 2 diabetes treated with tirzepatide or placebo (SURPASS-1)
    Boye, K.
    Yu, M.
    Lee, C. J.
    Mao, H.
    Cui, X.
    Lando, L. Fernandez
    Thieu, V.
    DIABETOLOGIA, 2021, 64 (SUPPL 1) : 246 - 247
  • [45] Outcomes of Antiviral Treatment for Influenza in Type 2 Diabetes
    Lewing, Benjamin D.
    Wallick, Christopher
    To, Tu My
    Masters III, Henry
    Dayal, Parul
    Korom, Stephan W.
    Tam, Selina
    AMERICAN JOURNAL OF MANAGED CARE, 2023, 29 (02): : E43 - E50
  • [46] Relationship between Body Weight Change and Glycemic Control with Tirzepatide Treatment in People with Type 2 Diabetes
    Pedersen, Sue
    Umpierrez, Guillermo E.
    Giorgino, Francesco
    Rodriguez, Angel
    Thieu, Vivian
    Sapin, Helene
    Lando, Laura Fernandez
    Karanikas, Chrisanthi A.
    Kiljanski, Jacek I.
    DIABETES, 2022, 71
  • [47] Patient-Reported Outcomes in Patients with Type 2 Diabetes Treated with Tirzepatide or Placebo (SURPASS-1)
    Boye, Kristina
    Yu, Maria
    Lee, Clare
    Mao, Huzhang
    Cui, Xuewei
    Lando, Laura Fernandez
    Thieu, Vivian
    DIABETES, 2021, 70
  • [48] Patient-Reported Outcomes in People with Type 2 Diabetes Receiving Tirzepatide in the SURPASS Clinical Trial Programme
    Boye, Kristina S. S.
    Thieu, Vivian Thuyanh
    Sapin, Helene
    Lee, Clare J. J.
    Lando, Laura Fernandez
    Brown, Katelyn
    Bray, Ross
    Wiese, Russell J. J.
    Patel, Hiren
    Rodriguez, Angel
    Yu, Maria
    DIABETES THERAPY, 2023, 14 (11) : 1833 - 1852
  • [49] Tirzepatide: A Double Agonist for Various People Living with Type 2 Diabetes
    Strollo, Felice
    Guarino, Giuseppina
    Satta, Ersilia
    Gentile, Sandro
    DIABETES THERAPY, 2024, 15 (09) : 1855 - 1860
  • [50] Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes
    Frias, Juan P.
    Davies, Melanie J.
    Rosenstock, Julio
    Manghi, Federico C. Perez
    Lando, Laura Fernandez
    Bergman, Brandon K.
    Liu, Bing
    Cui, Xuewei
    Brown, Katelyn
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (06): : 503 - 515
12345